Abstract Oncological Genetic Counselling (CGO) allows the identification of a genetic component that increases the risk of developing a cancer. Individuals' psychological reactions are influenced by both the content of the received information and the subjective perception of their own risk of becoming ill or being a carrier of a genetic mutation. This study included 120 participants who underwent genetic counselling for breast and/or ovarian cancer. The aim of the study was to examine the relation between their cancer risk perception and the genetic risk during CGO before receiving genetic test results, considering the influence of some psychological variables, in particular distress, anxiety and depression. Participants completed the following tools during a psychological interview: a socio-demographic form, Cancer Risk Perception (CRP) and Genetic Risk Perception (GRP), Hospital Anxiety and Depression Scale (HADS) and Distress Thermometer (DT). The data seem to confirm our hypothesis. Positive and significant correlations were found between the observed variables. Moreover, genetic risk perception determined an increase in depressive symptomatology and cancer risk perception led to an increase in anxious symptomatology, specifically in participants during cancer treatment. The present results suggest the importance of assessing genetic and cancer risk perception in individuals who undergo CGO, to identify those who are at risk of a decrease in psychological well-being and of developing greater psychological distress.
Introduction
Genetic counselling is defined by the National Society of Genetic Counsellors (NSGC) as Ba process of helping people understand and adapt to the medical, psychological and familial implications of genetic contributions to disease. This process integrates the following: interpretation of family and medical histories to assess the chance of disease occurrence or recurrence; education about inheritance, testing, management, prevention, resources and research; counseling to promote informed choices and adaptation to the risk or condition^ (Resta et al. 2006, p.27) .
In a setting of Oncological Genetic Counselling (CGO), the concept of risk is particularly important in that genetic risk, as a Bpredisposing condition,^takes on a dual significance: objective significance on the one hand (i.e., quantification of the chances of developing the disease), and subjective significance on the other (i.e., a purely individual perception of one^s own level of vulnerability) (Heshka et al. 2008; NCC Clinical Practice Guidelines 2016) . Risk perception seems to be influenced by cognitive, social and cultural factors (Leblond et al. 2011) . Psychological reactions to the outcome of genetic tests are associated both with the content of the received information, and with the subjective perception of one^s own risk of developing the disease (Godino et al. 2016) . Borreani et al. (2014) found that perception of cancer risk was theoretically and empirically relevant in motivating cancer screening and risk reduction behaviours. Individuals who underestimate their risk of developing cancer may be less likely to engage in healthprotective behaviours, whereas those who overestimate their risk may worry excessively, exhibiting behavior dependent on the health care system (Culver et al. 2013; Gopie et al. 2012) .
Cancer risk perception is associated with health-related quality of life, including psychological adjustment and health behaviours (Smith et al. 2008; Cull et al. 2001) . A person could experience a temporary state of anxiety during a counselling session, but this does not necessarily mean that s/he experiences permanent anxiety in daily life. Instead, other studies have reported that psychological distress (in particular, cancer-specific-distress) was significantly associated with refusal or withdrawal from genetic counselling, whether levels of distress were high or low. A moderate level of distress (general distress and cancer-specific-distress) was found to facilitate the decision to undergo genetic counselling (Cabrera et al. 2010; Christie et al. 2012; Voorwinden and Jaspers 2016) .
The impact of counselling processes and genetic testing can have clinical consequences (indicating the need for appropriate medical management), psychological consequences (providing potential answers to distress), and social consequences (informing the way to communicate risk to one's family) (Smerecnik et al. 2009; Trepanier et al. 2004; Contegiacomo et al. 2004; Wevers et al. 2015) . Risk perception, anxiety and distress levels act as key factors in the patient^s decision process throughout counselling and in decisions about preventive surgery (Cabrera et al. 2010; Rantala et al. 2009; Tong et al. 2015) . Those psychological variables, in accordance with the literature reported in this article, are considered moderators and/or predictive factors with respect to the degree of compliance with monitoring programmes and intra-family communication. Identification and intervention regarding emotional, cognitive and behavioural variables may promote adherence to monitoring programmes, and promote decision-making and empowerment (Meiser 2005; Voorwinden and Jaspers 2016; Elwyn and Miron-Shatz 2010; Halpern 2012; Levine et al. 2012; Peter et al. 2014) .
Thus, the aim of the study was to examine the relation between cancer risk perception and genetic risk in a sample of individuals undertaking oncological genetic counselling, considering the influence of some psychological variables, in particular distress, anxiety and depression. The influence of select demographic and medical characteristics were also investigated. In addition, we examined possible differences between the proband and family members. Specifically, our objectives were to: a. Investigate the levels of state anxiety, depression and distress in the involved participants. Given the complexity of hereditary and familial cancer, anxiety and depression are aspects of the psychological impact linked to the risk and susceptibility for genetic tumours (Claes et al. 2005; Dieng et al. 2014; Godino et al. 2016 ).
b. Evaluate whether there are significant differences among proband and family members during the specific clinical phases (pre-cancer treatment, in-cancer treatment and cancer treatment follow-up) in relation to the investigated variables. According to the literature, we hypothesize depression and distress levels are higher in the pre-treatment and in-treatment clinical stages (Borreani et al. 2014 ). c. Understand whether genetic risk perception and cancer risk perception are significantly associated with levels of anxiety, depression and distress within the whole sample. Based on published data (Heshka et al. 2008; Smith et al. 2008) , it is possible to find significant correlations between the assessed variables. Specifically, we expect to demonstrate how genetic risk perception and disease perception can affect the development of anxious and depressive symptoms. d. Evaluate in the two proband and family groups, the possible connection between genetic and cancer risk perception and the assessed psychological variables. We postulate that individuals who are the first to undertake counselling and exhibit a diagnosis of oncological disease, have a burden of family responsibilities that leads to depressive symptomatology, while family members who are facing the disease can exhibit anxious symptomatology.
Methods

Participants
This study included 120 participants who underwent CGO for breast and/or ovarian cancer, at the Oncology Section of the Regional Reference Centre for the Diagnosis and Cure of Rare and Hereditary-familial Tumours of Palermo, Italy. The 120 participants are divided into two groups of 60 people each, one group (indicated as PG) is constituted of probands (younger members of a family affected by the disease, who first undertake genetic counselling), and the other group (indicated as FG) constituted of family members who undertake genetic counselling for hereditary breast and/or ovarian cancer, following communications regarding risk within the family. In our study, the family members were relatives of the probands. Additional criteria for participation included being between the ages of 18 and 75 years. Following a preliminary review of responses to the socio-demographic form, we excluded from the research individuals who did not have an adequate level of understanding of the Italian language and those who had obvious psychiatric disorders (i.e., intellectual disabilities, severe psychotic symptoms) that prevented them from understanding the goals of the research and survey questions.
Instrumentation
-Socio-demographic form. This form is specially constituted for use during counselling, making it useful both for the collection of socio-demographic data and for understanding information obtained during counselling. The socio-demographic variables assessed were: age, gender, place of birth, civil status, education, employment, number of relatives affected by cancer (Catania et al. 2016 ). -Cancer Risk Perception (CRP) (Lerman et al. 2002) .
One self-report item was taken from prior research to evaluate perceptions of the possible risk of the individual developing cancer: "Mark with a cross on a scale of 0 to 100 what you consider to be your risk of developing, or redeveloping, breast and ovarian cancer." Responses are given on a Visual analogue scale of 0 to 100% (Where 0 represents the lowest risk, 100 the highest risk, and a blank space indicates BI do not know^). -Genetic Risk Perception (GRP) (Lerman et al. 2002) .
A single self-report item was taken from prior research to evaluate perceptions of the likelihood of being a carrier of the BRCA1/BRCA2 genetic mutation: "Mark with a cross on a scale of 0 to 100 what you consider to be your risk of being a carrier of the genetic mutation predisposing one to breast and ovarian cancer." Responses are given on a Visual analogue scale of 0 to 100% (Where 0 represents the lowest risk, 100 the highest risk, and a blank space indicates BI do not know^). -Hospital Anxiety and Depression Scale (HADS) (Costantini et al. 1999; Zigmond and Snaith 1983) . The Italian version of the BHospital Anxiety and Depression Scale^is commonly used to evaluate psychological distress in non-psychiatric settings. It is composed of two scales -anxiety (7 items) and depression (7 items). Items are rated on 4-point Likert scale and range from 0 to 3, with higher scores indicating greater anxiety and depression, respectively. The two scores can be calculated separately with three cut-offs: normal (0-7), borderline (8-10), disturbance ( > 11). In the present study, the HADS demonstrated a good internal consistency with a Cronbach's α value of .91 for HADS-A and .90 for HADS-D. -Distress Thermometer (DT) (Gil et al. 2005) . The DT is a basic, single item initial screening question which identifies an individual's distress coming from any source. It is rated on a visual analogue pain scale, where 0 means Bno distress,^and 10 means Bextreme distress.Î ndividuals are asked to respond by marking the place on the scale Bthat best describes how much distress you have been experiencing in five problem areas in the past weeks, including today.^P rocedures The assessment was carried out by trained researchers; all participants were informed about the study purposes, and they signed the informed consent before the assessment. Those who agreed were asked to complete a protocol containing paper pencil self-report measures. The time for completion was about 30 min. The self-report administration was conducted on the healthcare premises to guarantee confidentiality; it occurred prior to delivering the results of genetic testing (pre-test). This study was reviewed and approved by the Ethics Committee of the Hospital University BP. Giaccone^of the University of Palermo.
Data Analysis
After checking the monovariate normality of distributions using skewness and kurtosis indices, we tested the multivariate normality between variables using Mardia's coefficient. Descriptive statistics were calculated (mean, standard deviation), and correlations between variables were calculated. The reliability of each scale was assessed using Cronbach's index of internal consistency. To examine differences between the average scores of the participants and value test (cut-off scores), One Sample t-tests were conducted. In order, to examine in depth the predictive role of subjective risk perception compared to anxiety and depression levels, a linear regression for the whole sample was conducted. Risk perception represented the dependent variable Y, while anxiety and depression represented independent variables X. Values of the coefficient of determination R 2 were examined (that represents the variability proportion between the Y observed values, as explained by the linear regression of Y over X), and also slope values (increase of Y at every increase of X units). Data were represented via scatter plot and regression line. A 0.05 p-value threshold was used to evaluate the significance of the obtained data. Data processing was performed with the Statistical System Statistical Package for Social Sciences (SPSS 19.0).
Results
Socio-Demographic Characteristics of Participants
First, we checked the normality through univariate indexes of Skewness and Kurtosis with acceptance threshold of ±1. No variables displayed violations of normality. The Kurtosis multivariate index of Mardia calculated on the 19 variables was equal to 322, just below the critical cut-off of 399. As shown in Table 1 , 90% of participants were women, and 10% were men. The average age of the participants was 44.95 (SD = 11.81). All participants were Italian. Fifteen percent of the sample were single, while 76% were married, 4% were separated/divorced and 5% were widowed. Among the probands and relatives, 47% had cancer, while 53% consisted of healthy family members. Thirty percent of the sample did not have oncological pathology, 10% had ovarian cancer, and 60% had breast cancer. For those individuals with cancer, the average age of illness onset was 39 years, and they followed a regime of chemotherapy with taxani, antracicline and target therapy. Concerning the clinical stage of the participants with cancer, 38% were undergoing chemotherapy, 54% were in follow-up, and 8% were in pre-treatment.
Analyses of Levels of Anxiety, Depression and Distress
In order to evaluate the anxiety, depression and distress levels of the participants, a comparative analysis of their average score and the assessment instruments^threshold (cut-off) value was made using One Sample t-tests. Results indicated anxiety, depression and distress t scores are significantly different (Table 2) . This could indicate possible anxious and depressive symptomatology that should be further investigated. Descriptive analyses of the psychological variables were examined in specific clinical stages (pre-treatment, in-treatment and follow-up) regarding the group of participants with clinically high scores (both probands and relatives). Descriptive statistical analyses were performed in order to better understand which psychological variables might arise during the different clinical stages that portray the cancer treatment pathway.
In this regard, referring only to the group of cancer-affected individuals, belonging to both the probands and family groups, we used the Kruskall-Wallis test to compare the average score of cancer-affected participants' variables in the three stages. The p-value of the Krushal-Wallis test was p < .001, so we can reject the idea that cancer-affected participants^(n.91) median scores on the psychometric tests, which are divided by clinical stage, are equal. Specifically, their scores were significantly different for the depression sub-scale of the HADS test and for the DT; they were higher in the pre-treatment and intreatment clinical stages (Table 3) .
Correlations between Risk Perception and Anxiety, Depression and Distress Levels
Outcomes of the correlation analysis showed that there are consistent and significant correlations between almost all of the variables we examined, confirming our hypotheses. The analysis of the correlations among genetic risk perception and cancer risk perception, the two sub-scales of the HADS (anxiety and depression) and the Distress Thermometer (DT), showed that genetic risk perception, unlike cancer risk perception, is significantly correlated not only to both of the While the HADS anxiety sub-scale was positively correlated with the other sub-scales, that is, with depression levels (r = .254 p < .01), and cancer risk perception (r = .445 p < .01), depression was significantly correlated only with genetic risk perception (r = .254 p < .01). Therefore, these data suggest anxiety, rather than depression, may be more influential (Table4).
Furthermore, we analysed the correlations between genetic risk perception and cancer risk perception, and we examined the psychological dimensions within the whole sample. By doing so, we better investigated how these correlations arise in the two groups, probands and relatives.
Specifically, the correlation, analyzed through the Pearson^s coefficient, allows us to observe how, in the proband group, genetic risk perception and cancer risk perception were significantly correlated only with depression (r = .258 p < .01; r = .343 p < .01) (Table 5) , whereas, in the family group, genetic risk perception was significantly correlated with all of the examined variables, and cancer risk perception was correlated only with genetic risk perception (r = .607 p < .01), anxiety (r = .529 p < .01) and distress (r = .411 p < .01), (Table 6) .
Risk Perception as a Predictive Factor in the Development of Psychopathological Symptoms
In order to examine in depth the role genetic/cancer risk perception has in the onset of anxious and/or depressive symptomatology, we applied a linear regression model on the whole sample. We began with an analysis of the dependency link between genetic and cancer risk perception and anxiety levels. Later, we evaluated the association of the same independent variables with depression levels. The linear regression analysis between risk perception (RP) and anxiety levels, measured with the HADS_ANX sub-scales, revealed that RP is a significant predictor of anxiety levels, showing a positive correlation with the HADS_ANX sub-scale (β = 0.377, p < 0.01). The explained variance, for the variable in this first analysis, is 40% (R 2 = 0.40) with a slope of 1.48 (P = 0.0022) (Fig. 1) . On the contrary, the linear regression analysis between the same independent variable, that is, risk perception (RP) and depression levels, showed a non-significant value, with a β value of 1.180 (p < 0.20). The explained variance results in 14% with a slope of 1.97 (P = 0.085) (Fig. 2) , which is a nonsignificant statistical finding.
Risk perception is then a moderating and/or predictive factor in the development of psychopathological symptomatology, and specifically affects anxiety levels more than it affects depression levels ( Table 7) .
Discussion
This study was designed to enhance understanding of the possible influence of risk during genetic counselling and testing for cancer. Thus, the aim of the study was to examine the relation between cancer risk perception and genetic risk in a sample of individuals undertaking oncological genetic counselling, considering the influence of some psychological variables, in particular distress, anxiety and depression. The influence of select demographic and medical characteristics were also investigated. Genetic risk perception and cancer risk Risk Perception and Psychological Distress in CGOperception were considered to be possible predictive and/or moderating factors in the onset of psychological symptomatology, such as distress, anxiety and depression.
Regarding our first hypothesis, we expected to detect signs of psychological distress in individuals involved in Oncological Genetic Counselling, primarily state anxiety and depression. Previous research on this relationship finds that a moderate level of psychological distress facilitates the decision to undergo genetic counselling and that the perceived risk of cancer was associated with depression, anxiety and worry about cancer (Cabrera, 2010; Christie et al. 2012; Wevers et al. 2015) . Anxiety and depression are variables previously identified as aspects of the psychological impact linked to the risk and susceptibility for genetic tumours (Claes et al. 2005; Dieng et al. 2014; Godino et al. 2016) . As expected, and in line with literature, we found that individuals in our sample had higher levels of anxiety and depressive symptoms; the levels were clinically significant, suggesting possible psychological disorder that should be further investigated. This is consistent with results obtained in previous research (Heshka et al. 2008; Smerecnik et al. 2009; Voorwinden and Jaspers 2016) .
Concerning our second objective, we hypothesized that depression and distress levels are higher in the pre-cancer treatment and in-cancer treatment clinical stages (Borreani et al. 2014) . With regards to this hypothesis, we found that One of our objectives was also to evaluate in the two proband and family groups, the possible connection between genetic and cancer risk perception and the assessed psychological variables.
Previous results indicate that genetic counseling for familial cancer is associated with improvement in knowledge and adverse effect on affective outcomes (Braithwaite et al. 2006; Pieterse et al. 2007 ). We obtained data consistent with prior research results. In particular, in the family group, there were high levels of anxiety, connected to the fear of facing preventive and/or therapeutic procedures linked to an oncological pathology, such as having to undertaking a genetic test and starting a monitoring pathway.
Another goal of our research was to understand whether genetic risk perception, and cancer risk perception can be associated with the levels of anxiety, depression and distress within the whole sample (Heshka et al. 2008; Smith et al. 2008) . Outcomes of the correlation analysis showed that there are consistent and significant correlations between almost all the variables we examined, confirming our supposition. In particular, the correlation analysis showed that genetic risk perception was significantly correlated to both anxiety and depression and also to cancer risk perception. Also, in the proband group, genetic risk perception and cancer risk perception were significantly correlated only with depression; in the family group, genetic risk perception was significantly correlated with all the examined variables, and cancer risk perception was also correlated with genetic risk, anxiety and distress.
Results also show that both genetic risk perception and cancer risk perception can affect the psychological patterns of participants. In particular, in line with our hypotheses, the linear regression analysis allowed us to observe that, in our sample, subjective risk perception was a stronger predictor of the development of anxious symptoms than of depressive symptoms. These findings are consistent with prior research (Coyne et al. 2000; Meiser 2005) 
Study Limitations
Although this study provides evidence about the relationship of risk perception and psychological symptoms for proband and family members at risk of or affected by cancer, some limitations need to be noted. The most obvious limitations of this study are the sample size and the sample recruitment modalities, which included obtaining individuals from one geographic region. The findings cannot be generalized to the general population. The inclusion/exclusion criteria used do not allow us to generalize our findings to patients with different culture/language. A linguistic adaptation of our tools and inclusion of larger and more culturally diverse samples will help to verify the present results and demonstrate their generalizability.
A second limitation concerns the cross-sectional character of the current study. Although the regression model provides some information about the relationships among variables, cross-sectional and correlational study designs do not allow one to draw firm conclusions regarding the causal order of variables, nor about changes over time. The directionality of the significant relationships obtained in this study has not yet been determined. Moreover, although the sample in this study contained the most prevalent hereditary cancer syndrome (breast and ovarian cancer), it is not clear whether these finding can be generalized to other, less common, forms of hereditary cancer.
Practice Implications
Although genetic testing for cancer is becoming more common, due to the recent introduction of Oncological Genetic Counselling in our country, studies regarding Italian subjects are still very sparse (Di Gaudio et al. 2012 ). According to a recent Italian study (Morasso et al. 2008) , it is necessary to Oncological Genetic Counselling services should help counselees understand information concerning their genetic risk. The decisional process includes the adoption of possible preventive behaviours, such as undertaking preventive surgery. Healthcare providers should attempt to assess the influence of risk perception on patients' therapeutic compliance and provide them with psychological support in order to facilitate their decision-making process, promote their communication with and involvement of family members, and help them manage their emotional distress. Furthermore, psychological counselling may be recommended to further assist individuals who have high level of anxiety, depression, and distress. These types of services may promote patient use of personal resources and thereby enhance patient empowerment.
Research Recommendations
Future studies should test the present model using a more representative sample, and they should be oriented towards the development of a longitudinal model to verify the directionality of the effects as well as changes in the effects over time. Future research should assess the most effective ways of influencing risk perception, therapeutic compliance, and psychological responses. Efforts should be aimed at both individuals affected with cancer and their family members.
Conclusions
This study showed the importance of taking into consideration, during the process of oncological genetic counseling, not only medical variables but also cognitive and emotional aspects from both the individual and family spheres, in order to assure adequate care of the patient. In a setting of Oncological Genetic Counselling, genetic risk perception and cancer risk perception are important variables that may affect the development of anxious and depressive symptomatology. The perceptions individuals have of events, and the importance they give to them, affect their emotional state and their health-related behaviours. Although genetic testing and genetic counselling can strongly influence prevention behaviours and well-being of the individuals and families who are at increased risk, they may also have adverse short-term effects on emotional well-being.
